Dima is Digitalized!

Recognized as one of the leaders in technology of Chicago, Dima Elissa has been incorporated into TechagotChi, a video game where you help these leaders and their companies grow. To see the app description or download visit:
https://itunes.apple.com/us/app/techagotchi/id1269310553?ls=1&mt=8 (IOS)
https://play.google.com/store/apps/details?id=com.eightbitstudios.chicagotechgotchi (Android)

Chicago Hack Night: Sex, Gender, and Innovation Gaps in Data and Design for Healthcare

Hindsight has it’s benefits. Today’s innovation and research communities are recognizing that the approaches to designing drugs devices and treatment have to change. They way most innovation have come to be excludes the personalized and individualized variables which play out differently based on sex and gender. If we truly want better outcomes in our physical…

TEDx Talk: “One Size Doesn’t Fit All”

One size doesn’t fit all, personalizing medicine” considers the story of gender as an outlier in medical research and a call for change to those sitting at the healthcare table and represented in clinical, instrument and medical research. Dima Elissa shares her story as an outlier and “accidental entrepreneur” and how her experiences helped to…


#WeareWTF: Dima Elissa Shares her Story at WTF Event

Press Release: Chicago, IL — Dima Elissa — On March 15, 2016, VisMed•3D’s CEO and Founder, Dima Elissa joined a host of powerhouse women in tech to discuss their experiences starting and growing businesses. Women Tech Founders (WTF) celebrates the stories of seasoned and compelling women leaders in technology through live events and media, such as this hosted at 1871…

3D Printing Op-Ed Article Published by MedicalExpo

Press Release: March 2, 2016, Chicago, IL — Dima Elissa — An op-ed article written by VisMed•3D’s CEO and Founder, Dima Elissa was published in MEDICALEXPO’s emagazine. Elissa wrote about the challenge of the ever-growing 3D printing industry, cost. FDA approval for the additive manufacturing processes is slowly taking shape, but until most are approved it…